Qui Tam Whistleblower Law Firm - Nationwide

K&M Represents Whistleblower in $45 Million Settlement against Par Pharmaceutical Company, Inc.

Kenney & McCafferty is proud to announce that it represents a key Par Pharmaceutical insider whose knowledge, information, and evidence were central to Par’s decision today to pay $45 million to settle civil and criminal allegations. The settlement resolves allegations that Par willfully defrauded Medicare, Medicaid, and other government funded health care programs in connection with the launch of a long-term care sales force to promote Megace ES for off-label uses, including weight loss in elderly patients.

Kenney & McCafferty represented whistleblower Christine Thompson, who filed a qui tam action against Par arising from this misconduct. As a result of her efforts in coming forward with this information as well as her assistance throughout the government’s investigation, Ms. Thompson is entitled to receive a percentage of the government’s civil recovery.

To read more about the Par case, including the complaint, click here.

K&M Represents Whistleblower in $762 Million Settlement against Amgen, Inc.

Kenney & McCafferty is proud to announce that it represents a key Amgen insider whose knowledge, information, and evidence were central to Amgen’s agreement today to plead guilty to criminal conduct and to pay more than $762 million in criminal fines and civil penalties and damages. The settlement resolves allegations that Amgen willfully defrauded Medicare, Medicaid, and other government funded health care programs in connection with its promotion of its multi-billion dollar drug Aranesp for off-label uses, including Anemia of Cancer, which endangered the lives of patients across the country, among other allegations.

Kenney & McCafferty represented whistleblower Jill Osiecki, who filed a qui tam action against Amgen arising from this marketing misconduct more than eight years ago. As a result of her efforts in coming forward with this information as well as her assistance throughout the government’s investigation, Ms. Osiecki is entitled to receive a percentage of the government’s civil recovery.

To read more about the whistleblower, and the Amgen case, including the settlement, the complaint, and a statement by Ms. Osiecki, click here.

K&M Represents Whistleblowers in Record Settlement against GlaxoSmithKline

PHILADELPHIA, July 2, 2012 - Kenney & McCafferty is proud to announce that GlaxoSmithKline has agreed to plead guilty to criminal conduct and to pay $3 billion in criminal and civil fines, penalties and damages to settle allegations that the company defrauded Medicare, Medicaid and other government funded health care programs in connection with its market practices for Advair, Wellbutrin, Paxil, Lamictal, Zofran, Imitrex, Lotronex, Flovent and Valtrex and Avandia. The settlement is the largest qui tam settlement in U.S. history.

Kenney & McCafferty represented Gregory Thorpe and Blair Hamrick, the first whistleblowers to file a qui tam action against GSK arising from this marketing misconduct nearly a decade ago. As part of the record-setting settlement, GSK agreed to pay $1.017 billion to settle civil claims brought by Thorpe and Hamrick under the False Claims Act. GSK agreed to pay an additional $757 million to resolve criminal allegations stemming from the activity alleged by Thorpe and Hamrick. As a result of their efforts in coming forward with this information as well as their assistance throughout the government’s investigation, Thorpe and Hamrick are entitled to receive a percentage of the government’s civil recovery.

To read more about the GSK case, including the settlement and case documents, click here.

Experience Matters

Kenney & McCafferty is a premier nationwide whistleblower firm. We have helped our clients recover more than $5 billion for the federal government and have represented whistleblowers in the three largest whistleblower cases to date, including, most recently, the $3 billion dollar settlement against GlaxoSmithKline, as well as the $2.3 billion dollar settlement against Pfizer and the $1.4 billion dollar settlement against Eli Lilly.

Kenney & McCafferty also has the longest track record of any firm representing tax whistleblowers in tax underpayment and tax fraud matters, having recovered hundreds of millions of dollars for the federal government on behalf of tax whistleblowers over the past ten years. Our firm also currently represents whistleblowers under the newly enacted SEC whistleblower provisions.

Our firm focuses exclusively on whistleblower cases. We have been representing whistleblowers for fifteen years in wide array of fraud matters including pharmaceutical, healthcare, defense, tax, and general service administrator fraud. Our team includes former federal prosecutors, former IRS agents, and experienced trial counsel. Our attorneys have consistently received the highest rankings in Martindale Hubbell and been listed among the Superlawyers.

Areas of Practice

The qui tam lawyers at Kenney & McCafferty have handled a wide range of whistleblower cases involving:

A Track Record of Success

Kenney & McCafferty has worked on a number of very high profile qui tam cases in recent years, and we were lead attorney in the largest recovery in the history of the False Claims Act. Some of these cases include:

$3.0 billion settlement against GlaxoSmithKline
$2.3 billion settlement against Pfizer
$1.4 billion settlement against Eli Lilly
$520 million settlement against AstraZeneca
$425 million settlement against Cephalon

For more information on our strong track record of success, please visit our Notable Cases page.

If you have knowledge of fraud or a false claim made against the government, please contact our qui tam lawyers today. Kenney & McCafferty attorneys will consult with you about your case, without obligation. All communications with Kenney & McCafferty attorneys during these consultation services are confidential and protected by the attorney-client privilege.